Business ❯ Pharmaceutical Industry

Drug Development

Clinical Trials Market Competition Clinical Research Market Trends Market Access Market Launch Market Approval Market Impact Regulatory Affairs FDA Approval

Engineered Bacteria Turn Waste Plastic Into Parkinson’s Drug, Study Shows

Published in Nature Sustainability, the lab-scale proof of concept now advances toward industrial optimization.

FDA Demands Placebo-Controlled Trial for UniQure’s Huntington’s Gene Therapy

Zealand Plunges as Roche Obesity Drug Posts 10.7% Weight Loss With Placebo‑Like Tolerability

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

FDA Approves First All-Oral, Fixed-Duration First-Line CLL/SLL Regimen: Calquence Plus Venetoclax

Boots Pilots First High‑Street Prescribing Service for Wegovy and Mounjaro

FDA Rejects Disc Medicine’s Bitopertin for EPP After Questioning Surrogate Endpoint

Brazil’s Chamber Fast-Tracks Bill to Enable Compulsory Licensing of Tirzepatide Drugs

Asundexian Cuts Recurrent Stroke 26% Without More Major Bleeding in Phase III

Anvisa Expands Wegovy and Ozempic Uses to Cardiovascular and Kidney Protection

Japan Starts OTC Sales of Emergency Contraceptive Norlevo Under Pharmacist Supervision

Medicare GLP-1 Use Surges as CMS Advances Coverage Expansion and Lilly Eyes Q2 Pill Launch

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Sarepta Reports 3-Year EMBARK Data Showing Elevidys Slows Duchenne Progression

Sanofi Pushes Amlitelimab Toward 2026 Filings After Mixed Phase 3 Readouts

Zydus Launches Low-Cost Nivolumab Biosimilar Tishtha in India After Court Greenlight

Valneva Pulls U.S. Filings for Chikungunya Vaccine as FDA Halts Trials Over Safety Review

Liraglutide Patent Expiry Triggers Cheaper Weight‑Loss Generics in Germany

Sun Pharma Launches Unloxcyt in U.S. for Advanced Cutaneous Squamous Cell Carcinoma

FDA Delays Two Drugs in National Priority Voucher Program After Safety, Efficacy Flags